Cargando…

Targeting Genomic Alterations in Squamous Cell Lung Cancer

Squamous cell lung cancer causes approximately 400,000 deaths worldwide per year. Identification of specific molecular alterations, such as activating mutations in the epidermal growth factor receptor kinase and echinoderm microtubule-associated protein-like 4/anaplastic lymphoma kinase fusions have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantripragada, Kalyan, Khurshid, Humera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733025/ https://www.ncbi.nlm.nih.gov/pubmed/23936763 http://dx.doi.org/10.3389/fonc.2013.00195

Ejemplares similares

A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer
por: Khurshid, Humera, et al.
Publicado: (2012)

Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas
por: Mantripragada, Kalyan, et al.
Publicado: (2015)

Promising Targets and Current Clinical Trials in Metastatic Squamous Cell Lung Cancer
por: Vincent, Mark D.
Publicado: (2014)

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
por: Friedlaender, Alex, et al.
Publicado: (2019)

Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
por: Wang, Yongsheng, et al.
Publicado: (2021)

Identification of Immune Subtypes of Lung Squamous Cell Carcinoma by Integrative Genome-Scale Analysis
por: Yin, Liyuan, et al.
Publicado: (2022)

Identifying Genomic Alterations in Small Cell Lung Cancer Using the Liquid Biopsy of Bronchial Washing Fluid
por: Zhai, Jinfang, et al.
Publicado: (2021)

EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes
por: Jin, Rui, et al.
Publicado: (2021)

KRAS Mutations in Squamous Cell Carcinomas of the Lung
por: Acker, Fabian, et al.
Publicado: (2021)

Genomic And Tumor Microenvironment Differences Between Cell Cycle Progression Pathway Altered/Non-Altered Patients With Lung Adenocarcinoma
por: Shan, Guangyao, et al.
Publicado: (2022)

Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line
por: Al-Farsi, Abdulaziz, et al.
Publicado: (2014)

Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
por: Melosky, Barbara
Publicado: (2014)

Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer
por: Zhuang, Yuan, et al.
Publicado: (2021)

The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma
por: Yang, Jian, et al.
Publicado: (2020)

Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer
por: Marima, Rahaba, et al.
Publicado: (2020)

Genomic Alterations in Human Papillomavirus–Positive and –Negative Conjunctival Squamous Cell Carcinomas
por: Ramberg, Ingvild, et al.
Publicado: (2021)

Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma
por: Yanagi, Teruki, et al.
Publicado: (2018)

Blood Serum From Head and Neck Squamous Cell Carcinoma Patients Induces Altered MicroRNA and Target Gene Expression Profile in Treated Cells
por: Allen, Brittany, et al.
Publicado: (2018)

Alterations of the Human Skin N- and O-Glycome in Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Möginger, Uwe, et al.
Publicado: (2018)

Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
por: Melosky, Barbara
Publicado: (2017)

Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer
por: Zhou, Rui, et al.
Publicado: (2023)

Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study
por: Masciale, Valentina, et al.
Publicado: (2019)

Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma
por: Cai, Lei, et al.
Publicado: (2021)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine
por: Soldera, Sara Victoria, et al.
Publicado: (2017)

Targeted Therapies and Biomarkers in Small Cell Lung Cancer
por: Taniguchi, Hirokazu, et al.
Publicado: (2020)

Targeting KRAS in Non-Small Cell Lung Cancer
por: Corral de la Fuente, Elena, et al.
Publicado: (2022)

Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine
por: Liu, Xing, et al.
Publicado: (2020)

Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma
por: Thind, Amarinder Singh, et al.
Publicado: (2022)

Genetic Alteration Profiling of Chinese Lung Adenocarcinoma and Its Effect on Targeted Therapy Efficacy
por: Liu, Jie, et al.
Publicado: (2021)

Role of cancer-associated fibroblasts in the progression, therapeutic resistance and targeted therapy of oesophageal squamous cell carcinoma
por: Xue, Mengying, et al.
Publicado: (2023)

Based on the Development and Verification of a Risk Stratification Nomogram: Predicting the Risk of Lung Cancer-Specific Mortality in Stage IIIA-N2 Unresectable Large Cell Lung Neuroendocrine Cancer Compared With Lung Squamous Cell Cancer and Lung Adenocarcinoma
por: Yang, Ying, et al.
Publicado: (2022)

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma From Chinese Patients
por: Pan, Lulu, et al.
Publicado: (2020)

Discovery, Significance, and Utility of JAK2 Mutation in Squamous Cell Carcinoma of the Lung
por: Hundal, Jasmin, et al.
Publicado: (2022)

Targeting Lung Cancer Stem Cells: Research and Clinical Impacts
por: Zakaria, Norashikin, et al.
Publicado: (2017)

The Molecular Landscape and Biological Alterations Induced by PRAS40-Knockout in Head and Neck Squamous Cell Carcinoma
por: Chen, Gang, et al.
Publicado: (2021)

Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer
por: Han, Yanjie, et al.
Publicado: (2023)

Chemoradiotherapy-Induced CD4(+) and CD8(+) T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma
por: Chen, Xi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ibnfich16ou63t4vh0fh95ecit